Green Tea EGCg may reduce Cancer Risk
Green tea (Camelia sinensis) is an abundant source of antioxidants – notably, epigallocatechin gallate (EGCg), the most potent reducer of IL-6, a powerful pro-inflammatory cytokine. Previous studies have suggested that supplements of green tea extract may confer a variety of cardiovascular and cancer protective effects.
More recently, Nagi B. Kumar, from the H. Lee Moffitt Cancer Center & Research Institute (Florida, United States), and colleagues enrolled 97 men who had premalignant prostate lesions or high-grade intraepithelial neoplasia. Tracking for changes in high-grade prostatic intraepithelial neoplasia (HGPIN) and/or atypical small acinar proliferation (ASAP), study participants were randomly assigned to receive either a supplement containing green tea extract (400 mg EGCg), or placebo, for one year.
The researchers observed that the man who receive the green tea supplement experienced reduced combined rates of HGPIN/ASAP, as well as decreased levels of Prostate Specific Antigen (PSA). The study authors report that: ” Daily intake of a standardized, decaffeinated catechin mixture containing 400 mg EGCG per day for 1 year accumulated in plasma and was well tolerated but did not reduce the likelihood of PCa in men with baseline [high-grade prostatic intraepithelial neoplasia] or [atypical small acinar proliferation].”
EGCg is also a powerful assistant in the fight against bone loss. Both Primary Osteoporosis and bone loss due to pathological reasons (cancer), involves elevated IL-6 levels. Clear EGCg may be a beneficial nutient to anyone’s protocol should bone loss exist. Purchase HERE